Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Management of metabolic complications and cardiovascular risk in HIV-infected patients.

Blanco F, San Román J, Vispo E, López M, Salto A, Abad V, Soriano V.

AIDS Rev. 2010 Oct-Dec;12(4):231-41. Review.

PMID:
21179187
2.

HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.

Kotler DP.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S79-85. doi: 10.1097/QAI.0b013e318186519c. Review.

PMID:
18725816
3.

Treatment of dyslipidaemia in HIV-infected persons.

Manuel O, Thiébaut R, Darioli R, Tarr PE.

Expert Opin Pharmacother. 2005 Aug;6(10):1619-45. Review.

PMID:
16086650
4.

Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.

Leonard EG, McComsey GA.

Infect Dis Clin North Am. 2005 Sep;19(3):713-29. Review.

PMID:
16102657
5.

Antiretroviral therapy with heart.

Randell P, Moyle G.

Am J Ther. 2009 Nov-Dec;16(6):579-84. doi: 10.1097/MJT.0b013e318192116f. Review.

PMID:
19940610
6.

HIV and increased risk of cardiovascular diseases.

Das S.

Sex Health. 2005;2(4):219-21. Review.

PMID:
16402668
7.

HIV infection and advanced age emerging epidemiological, clinical, and management issues.

Manfredi R.

Ageing Res Rev. 2004 Jan;3(1):31-54. Review.

PMID:
15164725
8.

First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).

Carosi G, Quiros-Roldan E, Torti C, Antinori A, Bevilacqua M, Bonadonna RC, Bonfanti P, Castagna A, Cauda R, d'Arminio-Monforte A, Di Gregorio P, Di Perri G, Esposito R, Fatuzzo F, Gervasoni C, Giannattasio C, Guaraldi G, Lazzarin A, Lo Caputo S, Maggi P, Mazzotta F, Moroni M, Prestileo T, Ranieri R, Rizzardini G, Russo R, Galli M; Members of the Italian Cardiovascular Risk Guidelines Working Group.

Infection. 2007 Jun;35(3):134-42.

PMID:
17565453
9.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

AIDS. 2003 May 23;17(8):1179-93.

PMID:
12819520
10.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
11.

[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].

Polo R, José Galindo M, Martínez E, Alvarez J, Arévalo JM, Asensi V, Cánoves D, Cáncer E, Collazos J, Estrada V, Gómez-Candela C, Johnston S, Locutura J, López-Aldeguer J, Lozano F, Miralles C, Muñoz-Sanz A, Ortega E, Pascua J, Pedrol E, Pulido F, San Martín M, Sanz J, Viciana P, Chamorro L; Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS).

Enferm Infecc Microbiol Clin. 2006 Feb;24(2):96-117. Spanish.

PMID:
16545318
12.

[Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].

Leclercq P, Blanc M.

Rev Prat. 2006 May 15;56(9):987-94. Review. French.

PMID:
16775979
13.

Cardiovascular disease risk factors in HIV-infected patients in the HAART era.

Galli M, Ridolfo AL, Gervasoni C.

Ann N Y Acad Sci. 2001 Nov;946:200-13. Review.

PMID:
11762987
14.

Lipid metabolism in treated HIV Infection.

Dubé MP, Cadden JJ.

Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):429-42. doi: 10.1016/j.beem.2011.04.004. Review.

PMID:
21663837
15.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
16.

Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differences.

Neumann T, Woiwod T, Neumann A, Miller M, Von Birgelen C, Volbracht L, Esser S, Brockmeyer N, Gerken G, Erbel R.

Eur J Med Res. 2004 May 28;9(5):267-72.

PMID:
15257881
17.
18.

Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.

Calza L, Manfredi R, Pocaterra D, Chiodo F.

J Infect. 2008 Jul;57(1):16-32. doi: 10.1016/j.jinf.2008.02.006. Epub 2008 Mar 21. Review.

PMID:
18358535
19.

HIV infection, antiretroviral therapy and cardiovascular risk.

Barbaro G.

J Cardiovasc Risk. 2002 Oct;9(5):295-300. Review.

PMID:
12394324
20.

Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.

Magen E, Elbirt D, Sthoeger Z.

Isr Med Assoc J. 2005 Apr;7(4):252-6. Review.

Supplemental Content

Support Center